NASDAQ$BTTC

Black Titan Corp · Q1 2016 earnings

Q1 2016 earnings · · Investor relations

Headline financials

EPS (adj)

-$324.00

Previous: -$1.20-26873.0%
Capital Expenditures

$57K

Previous: $7K+714.3%
Net Income

-$1.85M

Previous: -$4.9M+62.3%
Operating Income

-$1.83M

Previous: -$1.62M-13.4%
Cash & Equivalents

$5.76M

Previous: $13.4M-57.1%
Total Assets

$12M

Previous: $18.4M-34.8%
Stock-Based Comp

$332K

Previous: $491K-32.4%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$0

Q2 2025
Beat estimate in 7 of 9 quarters(78%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro